Trial Profile
A Single Center, Randomized, Open-Label, Crossover Study, Comparing the Pharmacodynamic Properties of Insulin VIAJECT, Regular Human Insulin, and Insulin Lispro Either in Combination With a Basal Insulin Infusion or With Insulin Glargine Relative to a Standardized Meal in Patients With Type 1 Diabetes.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Oct 2011
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Insulin glargine; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Biodel
- 04 Nov 2009 New trial record